Motor assessment
OtherAn occupational therapist install the patient sitting in front of the test board and tell him the instructions
NCT Number: NCT03223051
The aim of this randomized study is to develop a new motor assessment of space exploration in a 2D environment with upper limbs for children with spinal muscular atrophy 1 and 2 from 3 until 16 years old.
Looking for future studies?
Notify Me3 year–16 year
All sexes
Interventional
Not applicable
Hopital Raymond Poincare, Garches, France
Thirty children are included in the prospective randomized study. They are evaluated with the new test, Space Exploration Test (TES), and with the Motor Function Measure (MFM), a gold standard scale. The objective is to compare the results and to demonstrate the complementarity of the two tools.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
An occupational therapist install the patient sitting in front of the test board and tell him the instructions
Time frame: 1 hour
Clinical Evaluation
Time frame: 20 minutes
The SET is made through a test board 170 cm long and 60 cm deep, developed by in our lab
Centre d'Investigation Clinique et Technologique 805
Other
Acronym: ExplorASI
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05341453
Central Nervous System Diseases, Motor Neuron Disease
Prague, Czechia
View Trial DetailsNCT07547189
Central Nervous System Diseases, Communication Disorders
Istanbul, Beykoz, Turkey (Türkiye)
View Trial DetailsNCT05794139
Central Nervous System Diseases, Motor Neuron Disease
Los Angeles, California, United States
View Trial DetailsNCT03689660
Biofeedback, Central Nervous System Diseases
Izmir, Balcova, Turkey (Türkiye)
View Trial Details